SPORULIN®, a U.S. patented, 3-strain combination of Bacillus subtilis probiotic, is a unique combination which withstands pelleting and is shown to inhibit many undesirable enteric bacteria in poultry. Recently released research has shown SPORULIN® modifies chicken microbiota, reducing C. perfringens and increasing Lactobacillus, when it is added to the feed.
SPORULIN® was originally developed by University of Arkansas scientists working in collaboration with Pacific Vet Group, a company now wholly owned by Novozymes, the Denmark based global leader in microbiological organism discovery, characterization and production.
For more information about SPORULIN®, visit http://www.novusint.com/Products/sporulin.
About Novus International, Inc.
Novus International, Inc. is headquartered in metropolitan St. Louis, Missouri, U.S.A. and serves customers in over 100 countries around the world. A global leader in developing animal health and nutrition solutions, Novus International's products include ALIMET® and MHA® feed supplements, ACTIVATE® nutritional feed acid, ACIDOMIX® preservative premixture, CIBENZA® enzyme feed additive, MINTREX® chelated trace minerals, SANTOQUIN® feed preservative, AGRADO® feed antioxidant and many other specialty ingredients. Stratum Nutrition, a division of Novus Nutrition Brands, LLC, focuses on human nutrition through specialty and functional ingredients for manufacturers of foods, beverages and dietary supplements (www.stratumnutrition.com).
Novus is privately owned by Mitsui & Co. (U.S.A.), Inc. and Nippon Soda Co., Ltd. For more information, visit www.novusint.com. ©2016 Novus International, Inc. All rights reserved.
CONTACT: Brandi Hamilton
Logo - http://photos.prnewswire.com/prnh/20160804/395786LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/novus-initiates-international-commercial-activities-for-sporulin-300309634.html
SOURCE Novus International, Inc.